Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA).

Item

http://www.wikidata.org/entity/Q36508824

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@ast

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@en

type

Item

label

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@ast

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@en

prefLabel

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@ast

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@en

P1476

Growth hormone receptor (GHR) ...... d immunosorbent assay (ELISA).

@en

P2093

David Hwang

http://www.w3.org/2001/XMLSchema#string

Gil Atzmon

http://www.w3.org/2001/XMLSchema#string

JunXiang Wan

http://www.w3.org/2001/XMLSchema#string

Jurgen Kratzsch

http://www.w3.org/2001/XMLSchema#string

Nir Barzlai

http://www.w3.org/2001/XMLSchema#string

Pinchas Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently

Unique lipoprotein phenotype and genotype associated with exceptional longevity

Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum

Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.

Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.

Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene.

A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.

The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a tw

Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.

The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.

P304

E77-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-2375

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23162096

http://www.w3.org/2001/XMLSchema#string

P932

3537082

http://www.w3.org/2001/XMLSchema#string